Acta Med. 2005, 48: 35-38

https://doi.org/10.14712/18059694.2018.26

Leukocyte Lipid Peroxidation, Superoxide Dismutase and Catalase Activities of Type 2 Diabetic Patients with Retinopathy

Naciye Kurtula, Ebubekir Bakanb, Hülya Aksoyb, Orhan Baykalc

aKSU, Kahramanmaras, Faculty of Science, Department of Chemistry, Turkey
bMedical School, Atatürk University, Department of Biochemistry, Erzurum, Turkey
cMedical School, Atatürk University, Department of Ophtalmology, Erzurum, Turkey

Received November 1, 2004
Accepted December 1, 2004

References

1. Akkus I, Kalak S, Vural H et al. Leukocyte LPO,superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 1996; 244:221–7. <https://doi.org/10.1016/0009-8981(96)83566-2>
2. Armstrong AM, Chestnutt JE, Gormley MJ, Young IS. The effect of dietary treatmenton lipid peroxidation and antioxidant status in newly diagnosed noninsulin dependent diabetes. Free Radic Biol Med 1996; 21(5):719–26. <https://doi.org/10.1016/0891-5849(96)00169-4>
3. Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003; 35(11):1491–9. <https://doi.org/10.1016/j.freeradbiomed.2003.08.018>
4. Draper HH and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990; 186:421–31. <https://doi.org/10.1016/0076-6879(90)86135-I>
5. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19(3):257–67. <https://doi.org/10.2337/diacare.19.3.257>
6. Halliwell B. Reactive oxygen species in living systems: Source, biochemistry, and role in human disease. Am J Med 1991; 91(3C):14–22S. <https://doi.org/10.1016/0002-9343(91)90279-7>
7. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1984; 1(8391):1396–7. <https://doi.org/10.1016/S0140-6736(84)91886-5>
8. Hammes HP, Weiss A, Führer D, Krämer HJ, Papavassilis C, Grimminger F. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids. Diabetologia 1996; 39:251–5. <https://doi.org/10.1007/BF00418338>
9. Ido Y, Kilo C, Williamson JR. Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia 1997; 40:S115–S7. <https://doi.org/10.1007/s001250051422>
10. Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989; 38:1539–43. <https://doi.org/10.2337/diab.38.12.1539>
11. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy 2000; 101(10):541–551.
12. Kanski JJ. Retinal vascular disorders. In: Kanski JJ.Clinical ophthalmolgy: A Systemic Approach. 3rd ed. England: Butterworth & Heinemann, 1994:344–69.
13. Kelmpner MS, Gallin JI. Separation and functional characterization of human neutrophil subpopulation. Blood 1978; 51:659–69.
14. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001; 53(1):33–9. <https://doi.org/10.1016/S0168-8227(01)00238-8>
15. Klein R, Klein BEK. Diabetic eye disease. Lancet 1997; 350:197–204. <https://doi.org/10.1016/S0140-6736(97)04195-0>
16. Kowluru RA, Kern TS, Engerman RL, Armstrong D. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 1996; 45(9):1233–7. <https://doi.org/10.2337/diab.45.9.1233>
17. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res 2003; 37(11):1169–80. <https://doi.org/10.1080/10715760310001604189>
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–75.
19. Luck H. Catalase. In: Bergmeyer HU, ed. Methods in Enzymatic Analysis. New York and London: Academic Press Inc., 1965:855–84.
20. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992; 15(2):256–60. <https://doi.org/10.2337/diacare.15.2.256>
21. Maxwell SRJ, Thomason H, Sandler D et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997; 27(6):484–90. <https://doi.org/10.1046/j.1365-2362.1997.1390687.x>
22. Muchova J, Liptakova A, Orszaghova Z et al. Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus. Diabet Med 1999; 16(1):74–8. <https://doi.org/10.1046/j.1464-5491.1999.00015.x>
23. Ookawara T, Kawamura N, Kitakawa Y, Taniguchi N. Site specific and random fragmentation of Cu, Zn-superoxide dismutase by glycation reaction. J Biol Chem 1992; 267:18505–10.
24. Schröder S, Palinski W, Schmid-Schönbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 1991; 139:81–100.
25. Sinclair AJ, Girling AJ, Gray L et al. An investigation of the relationship between free radical activity and vitamin C metabolism in elderly diabetic subjects with retinopathy. Gerontology 1992; 38:268–74. <https://doi.org/10.1159/000213339>
26. Strother RM, Thomas TG, Otsyula M, Sanders RA, Watkins JB 3rd. Characterization of oxidative stress in various tissues of diabetic and galactose-fed rats. Int J Exp Diabetes Res 1992; 2(3):211–6. <https://doi.org/10.1155/EDR.2001.211> <PubMed>
27. Sun Y, Oberlay LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34:497–500.
28. Thornalley PJ. Advanced glycation and the development of diabetic complications: Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol and Metab 1996; 3(3):149–66.
29. Türk, HM, Sevinc, A, Camci, C et al. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol 2002; 39(3):117–22. <https://doi.org/10.1007/s005920200029>
30. Uchimura K, Nagasaka A, Hayashi R et al. Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J Diabetes Complications 1999; 13(5–6):264–70. <https://doi.org/10.1016/S1056-8727(99)00053-7>
31. Uzel N, Sivas A, Uysal M, Öz H. Erythrocyte LPO and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metabol Res 1987; 19:89–90. <https://doi.org/10.1055/s-2007-1011748>
32. Vučić M, Gavella M, Božikov V, Ashcroft SJH, Ročić B. Superoxide dismutase activity in lymphocytes and polymorphonuclear cells of diabetic patients. Clin Chem Clin Biochem 1997; 35(7):517–21.
33. Yang X, Borg LA, Eriksson UJ. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 1997; 272(1 Pt 1):E173–E80. <https://doi.org/10.1152/ajpcell.1997.272.1.C142>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive